
Shares of healthcare firm Allurion Technologies ALUR.N rise 6.19% to $1.31
Co says it partnered with Argentine companies Bionut and Farmastar to offer discounted access to Eli Lilly's LLY.N weight-loss pill, Mounjaro, alongside ALUR's swallowable Smart Capsule in Argentina
The Smart Capsule is a tiny pill that can track pH, temperature or gut biomarkers from inside the digestive tract to monitor gut health - co
Co says a study of 76 patients combining low‑dose Mounjaro with its capsule led to 23% average weight loss over one year, with lower side effects and no dropouts
Co says the Smart Capsule is not yet approved in the U.S.; it is exploring similar tie‑ups in other countries
Shares of ALUR fell ~89% in 2025